![]() The EDQM and MHLW (Japan) signed a Memorandum of Co-operation which defines concrete measures for strengthening collaboration between the European and Japanese Pharmacopoeias (Ph. This new agreement is aimed at promoting co-operation on the safety and quality of medicines in China and Europe. The EDQM and the Chinese Pharmacopoeia Commission (ChP) announced the signing of a new Memorandum of Understanding (MOU) for the next four years. The EDQM and the ANVISA announced the signing of a Memorandum of Understanding (MOU) on their intention to strengthen relations and promote further co-operation in the field of medicines’ quality and science-based pharmacopoeial standards. The EDQM and the ANVISA, the Health Surveillance Agency of Brazil, signed a Memorandum of Understanding which lays the foundation for ANVISA to consider the use of Certificates of suitability to the monographs of the European Pharmacopoeia (CEPs) for their evaluation of marketing authorisation applications (MAAs) for medicinal products. More information on the cooperation between the EDQM and the EMA. It is part of the efforts of the EDQM, the EU Commission and the EMA to make the best use of resources for ensuring the quality of medicines and the protection of public health in Europe. The agreement will facilitate the transfer of regulatory information within the context of current legislation on data protection and confidential information. ![]() The EDQM also signed a confidentiality agreement with the European Medicines Agency (EMA) and the EU Commission (Directorate General Health) on the exchange of non-public information on medicinal products. This agreement will allow both parties to exchange confidential information on the quality of active pharmaceutical ingredients (CEPs and DMF procedures) and the outcome of inspections of manufacturing sites. The EDQM and the Ministry of Food and Drug Safety of the Republic of Korea signed a Memorandum of Confidentiality (MOC) on Information Exchange. This agreement will allow both parties to exchange confidential information on the quality of active pharmaceutical ingredients and the outcome of inspections of manufacturing sites. The EDQM and the Saudi Food and Drug Administration signed a Memorandum of Understanding (MOU) via an online signing ceremony. It also opens the way for other forms of co-operation on issues of mutual interest. This agreement will allow both parties to exchange pharmacopoeial texts and materials, regulatory and technical documentation, and experience in the pharmacopoeial analysis of medicines. The EEC is the permanent regulatory body of the Eurasian Economic Union (EAEU), comprising five member states (the Republic of Armenia, the Republic of Belarus, the Republic of Kazakhstan, the Kyrgyz Republic and the Russian Federation). The EDQM and the Eurasian Economic Commission (EEC) signed a Memorandum of Understanding in May 2021. This list is subject to modifications, and is provided for information purposes only. Lists of agreements concluded by the EDQM, Council of Europe, with other international intergovernmental organisations or public international institutions Institutions for organ donation and transplantation in our Member States Official Cosmetics Control Laboratories (OCCL)Ĭatalogue of events and training resourcesĮuropean Pharmacopoeia 11th Edition Conference highlightsĮuropean Day for Organ Donation and Transplantation (EODD) ![]() Biological Standardisation Programme (BSP) ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |